Determining the optimal 5-FU therapeutic dosage in the treatment of colorectal cancer patients

Fluorouracil (5-FU) has been wildly used as a primary medication in the treatment of solid tumors including colorectal cancer. The treatment efficacy and toxicity of 5-FU varies greatly among individuals, suggesting a need for individualized regimen for cancer patients. The present study analyzed th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Ling, Jiang, Yi, Yang, Yuxian, Zheng, Yuqiong, Zheng, Jin, Jiang, Hong, Zhang, Shengqi, Lin, Lifang, Zheng, Jieting, Zhang, Shuyao, Zhuang, Xiaowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348438/
https://www.ncbi.nlm.nih.gov/pubmed/27636992
http://dx.doi.org/10.18632/oncotarget.11980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348438/
https://www.ncbi.nlm.nih.gov/pubmed/27636992
http://dx.doi.org/10.18632/oncotarget.11980

Ejemplares similares